Stay updated on TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A new version of the clinical trial record was submitted on 2026-11-02, updating the study status and contacts/locations. It replaces the previously listed 2026-06-23 version.
    Difference
    0.3%
    Check dated 2026-11-08T06:17:59.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-01T04:12:40.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces an update to terminology, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition.
    Difference
    0.4%
    Check dated 2026-10-25T05:28:46.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T04:46:01.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The site footer now identifies the software as revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T06:42:05.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The footer revision tag was updated from v3.6.6 to v3.7.0, signaling a platform software update to the history view. It does not modify the recorded study data or history entries.
    Difference
    0.1%
    Check dated 2026-09-20T03:06:29.000Z thumbnail image

Stay in the know with updates to TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page.